WILKO DECONGESTANT

Posology Adults and Elderly While holding upright the spray nozzle should be inserted into each nostril in turn and squeezed lightly twice while breathing in. The application may be repeated up to 2 times a day, or used at bedtime to give relief through the night.

Children Do not give to children under 12 years of age. 05% Nasal Spray should not be used for more than 7 consecutive days. Method of administration For nasal use. 4)

The active ingredient is usually well tolerated in normal use.

For the frequency of occurrence of side effects, the following phrases are used:

Very common (≥ 1/10); Common (≥ 1/100 to <1/10); Uncommon (≥ 1/1,000 to <1/100); Rare (≥ 1/10,000 to <1/1,000); Very rare (<1/10,000); Unknown (cannot be estimated from the available data). g. contact dermatitis) (Dermatitis contact) Skin discolouration (as this product contains thiomersal) (Skin discolouration) Exanthema (Rash) Skin rashes (Rash) Itching (Pruritus) Unknown General disorders and administration site conditions Irritability (Irritability) Tolerance (Drug tolerance) with diminished effect (Drug effect decreased) Vasodilation in rebound congestion (Rebound effect) Weakness (Asthenia) Pain (Pain) Unknown Investigations Increased blood pressure (Blood pressure increased) Unknown Prolonged and/or heavy use of oxymetazoline may lead to reduced effect and/or rebound congestion (rhinitis medicamentosa), cardiovascular effects and/or CNS effects.

Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. uk/yellowcard.

If symptoms persist or do not improve after 7 days, a doctor should be consulted. This medicinal product should be used for no more than 7 consecutive days to avoid rebound-effect and drug induced rhinitis (rhinitis medicamentosa). This medicinal product should be used with caution in patients with prostatic hypertrophy (as there is a risk of acute urinary retention) and the elderly.

Consult a doctor before using this medicine in case of: • Hepatic and renal disorders. g. amitriptyline, imipramine). • Use with caution in occlusive vascular disease. • If any of the following occur, using this medicine should be stopped: o Hallucinations o Restlessness o Sleep disturbances.

Keep away from eyes. Keep all medicines out of the sight and reach of children. This medicinal product contains benzalkonium chloride as a preservative which may cause swelling of the nasal mucosa, especially during long-term use. If such a reaction (persistent nasal congestion) is suspected, a product for nasal administration which contains no preservative should be used if possible.

If such products for nasal administration are not available without preservative, the use of another dosage form should be considered. Benzalkonium chloride may also cause bronchospasm. 4 mg benzalkonium chloride in each 1ml which is equivalent to 6 mg/15ml and 8mg/20ml.

Benzalkonium chloride may cause irritation or swelling inside the nose, especially if used for a long time. This medicinal product contains thiomersal (an organomercuric compound) as a preservative and therefore, it is possible that sensitisation reactions may occur.

1. Patients suffering from phaeochromocytoma. Patients who have had trans-sphenoidal hypophysectomy (removal of the pituitary gland). Patients who have recently had nasal or sinus surgery. 5). Patients who have inflamed skin or mucous membranes of their nostrils or have scabs in their nose.

Patients suffering from cardiovascular disease (including hypertension). Patients suffering from diabetes mellitus. Patients suffering from hyperthyroidism. Patients suffering from closed-angle glaucoma. 5). 5). This product should not be used in patients with atrophic rhinitis or rhinitis sicca.

Children under 12 years of age.